| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/21/2011 | WO2011008956A3 Mammalian genes involved in infection |
| 07/21/2011 | WO2011008947A3 Treatment and diagnosis of immune disorders |
| 07/21/2011 | WO2010135749A9 Herpes simplex virus type2: compositions and methods for eliciting an immune response |
| 07/21/2011 | US20110179506 New i-crei derived single-chain meganuclease and uses thereof |
| 07/21/2011 | US20110178488 Sexual Hygienic Composition |
| 07/21/2011 | US20110178277 Stabilized single domain antibodies |
| 07/21/2011 | US20110178183 Use Of Polyether-Based And Vinyl Monomer-Based Copolymers As Binders For Dosing Forms Comprising Solid Active Ingredients |
| 07/21/2011 | US20110178176 Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses |
| 07/21/2011 | US20110178167 Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using terminalia catappa leaf extract |
| 07/21/2011 | US20110178142 Pharmaceutical composition for therapeutic or prophylactic treatment of bacterial infections and associated diseases |
| 07/21/2011 | US20110178129 Inhibitors of flaviviridae viruses |
| 07/21/2011 | US20110178124 Pyridinium and quinolinium derivatives |
| 07/21/2011 | US20110178123 Nonpeptide hiv-1 protease inhibitors |
| 07/21/2011 | US20110178120 Hiv integrase inhibitors from pyridoxine |
| 07/21/2011 | US20110178108 Group of amino substituted benzoyl derivatives and their preparation and their use |
| 07/21/2011 | US20110178107 Hcv protease inhibitors |
| 07/21/2011 | US20110178106 5-quinolinone and imidazopyridine compounds and use thereof |
| 07/21/2011 | US20110178096 Octahydropentalene compounds as chemokine receptor antagonists |
| 07/21/2011 | US20110178092 HIV-1 Protease Inhibitors |
| 07/21/2011 | US20110178077 Anti-infective compounds |
| 07/21/2011 | US20110178074 Antipathogenic benzamide compounds |
| 07/21/2011 | US20110178071 Antiviral Treatments |
| 07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
| 07/21/2011 | US20110178064 Spiro condensed barbituric acid derivatives for use as antibacterial |
| 07/21/2011 | US20110178058 Inhibitors of flaviviridae viruses |
| 07/21/2011 | US20110178056 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 07/21/2011 | US20110178044 Transdermal administration of hydrophilic drugs using permeation enhancer composition |
| 07/21/2011 | US20110178043 Inhibitors of the mevalonate pathway of streptococcus pneumoniae |
| 07/21/2011 | US20110178042 Hydroxamic Acid Derivatives Useful as Antibacterial Agents |
| 07/21/2011 | US20110178038 Indole Antiviral Compositions And Methods |
| 07/21/2011 | US20110178037 Hydrophobically enhanced aminoglycosides |
| 07/21/2011 | US20110178031 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid |
| 07/21/2011 | US20110178028 Method for the detection of proventricular dilatation disease and kit thereof |
| 07/21/2011 | US20110178004 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 07/21/2011 | US20110178003 Optimized dengue virus entry inhibitory peptide (10an) |
| 07/21/2011 | US20110178002 High Affinity Ligands Bind to Clostridium Difficile Toxin A |
| 07/21/2011 | US20110178001 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 07/21/2011 | US20110178000 Apoptotically Active Peptides |
| 07/21/2011 | US20110177951 Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177180 Herbal composition and method for the treatment of viral infection |
| 07/21/2011 | US20110177171 Oxygenated Ophthalmic Compositions and Methods of Use |
| 07/21/2011 | US20110177163 Compositions and methods for treating hepatitis a |
| 07/21/2011 | US20110177160 Amino acid lipids and uses thereof |
| 07/21/2011 | US20110177150 Implantable tissue compositions and method |
| 07/21/2011 | US20110177131 siRNA SILENCING OF FILOVIRUS GENE EXPRESSION |
| 07/21/2011 | US20110177127 Brucella Abortus Proteins and Methods of Use Thereof |
| 07/21/2011 | US20110177126 Bacteria and derived products to reinforce the body defences and to reduce the risk of disease |
| 07/21/2011 | US20110177125 Hsv-1 and hsv-2 vaccines and methods of use thereof |
| 07/21/2011 | US20110177124 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/21/2011 | US20110177123 Recombinant Live Attenuated Foot-and-Mouth Disease (FMD) Vaccine Containing Mutations in the L Protein Coding Region |
| 07/21/2011 | US20110177121 Immunogenic Influenza Composition |
| 07/21/2011 | US20110177120 Mycobacterium tuberculosis vaccine |
| 07/21/2011 | US20110177117 Chimeric respiratory syncytial virus polypeptide antigens |
| 07/21/2011 | US20110177116 Methods of Immunizing Pregnant Heifers at Three Months of Gestation |
| 07/21/2011 | US20110177114 Immediate protection against pathogens via mva |
| 07/21/2011 | US20110177112 Multi- component l2 vaccine for prevention of human papilloma virus infection |
| 07/21/2011 | US20110177111 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens |
| 07/21/2011 | US20110177110 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 07/21/2011 | US20110177106 Novel Therapeutic Methods for Treating Inflammation and Immune System Disorders |
| 07/21/2011 | US20110177105 Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their Therapeutic Applications |
| 07/21/2011 | US20110177090 Glycan markers and autoantibody signatures in HIV-1 and HIV-1-associated malignancies |
| 07/21/2011 | US20110177081 Pharmaceutical compositions of antibodies for diseases caused by viruses |
| 07/21/2011 | US20110177055 Compounds and compositions as channel activating protease inhibitors |
| 07/21/2011 | US20110177050 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/21/2011 | US20110177049 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/21/2011 | US20110177048 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/21/2011 | US20110177035 Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease |
| 07/21/2011 | US20110177030 Hepatitis C Inhibitor Compounds |
| 07/21/2011 | US20110177028 Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| 07/21/2011 | US20110177022 Mammalian Cytokines; Related Reagents and Methods |
| 07/21/2011 | US20110176998 Imaging and therapy of virus-associated tumors |
| 07/21/2011 | CA2799474A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | CA2787529A1 Treatment of chlamydiaceae infections by means of beta-lactams |
| 07/21/2011 | CA2786660A1 Liver targeting molecules |
| 07/21/2011 | CA2786329A1 Anti - infective pyrido (1,2-a) pyrimidines |
| 07/21/2011 | CA2785567A1 Inhibitors of flaviviridae viruses |
| 07/21/2011 | CA2785563A1 Inhibitors of flaviviridae viruses |
| 07/21/2011 | CA2784033A1 A method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection |
| 07/20/2011 | EP2345728A1 Yeast membrane protein expression system and its application in drug screening |
| 07/20/2011 | EP2345721A1 Recombinant gelatin in vaccines |
| 07/20/2011 | EP2345720A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 07/20/2011 | EP2345716A1 Recombinant influenza viruses for vaccines and gene therapy |
| 07/20/2011 | EP2345665A2 Flavivirus NS1 subunit vaccine |
| 07/20/2011 | EP2345661A1 Modified fluorinated nucleoside analogues |
| 07/20/2011 | EP2345660A1 Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent |
| 07/20/2011 | EP2345659A1 Modified fluorinated nucleoside analogues |
| 07/20/2011 | EP2345658A1 Modified fluorinated nucleoside analogues |
| 07/20/2011 | EP2345657A1 Modified fluorinated nucleoside analogues |
| 07/20/2011 | EP2345656A1 Helicobacter pylori bacterium proliferation inhibitor |
| 07/20/2011 | EP2345650A1 Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent |
| 07/20/2011 | EP2345643A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
| 07/20/2011 | EP2345642A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
| 07/20/2011 | EP2345641A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives |
| 07/20/2011 | EP2345420A1 Use of a TH1 immune response inducing adjuvant for enhancing immune responses |
| 07/20/2011 | EP2345419A1 Mucosal vaccine using cationic nanogel |
| 07/20/2011 | EP2345411A1 Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| 07/20/2011 | EP2344638A1 Compositions and methods for inhibiting expression of an rna from west nile virus |
| 07/20/2011 | EP2344542A2 Tubercolosis vaccines targeted to cd40 |
| 07/20/2011 | EP2344523A1 Combination gas vaccines and therapeutics |